Physician profile
Cindy Ng
NPI 1154826386
$2,913.47
in general payments reported to CMS, 2019-2025
21 companies · $34.51 in 2025
The $34.51 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,235 · 2023: $1,010 · 2024: $634 · 2025: $34.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,200.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $614.80 | 2023-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $298.56 | 2022-2024 | Xtampza |
| Medtronic, INC. | $185.10 | 2023-2024 | Intellis Adaptivestim |
| Scilex Pharmaceuticals INC. | $152.49 | 2023-2024 | Ztlido |
| Idorsia Pharmaceuticals US INC | $75.21 | 2023-2024 | Quviviq |
| Hydrocision, INC. | $54.31 | 2022-2025 | Tenjet |
| Azurity Pharmaceuticals, INC. | $38.81 | 2024 | Horizant |
| Valinor Pharma, LLC | $30.84 | 2023-2024 | Movantik |
| Curonix LLC | $30.75 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $27.79 | 2023-2024 | Proclaim, Eterna |
| Alnylam Pharmaceuticals INC. | $27.04 | 2023 | Oxlumo |
| Averitas Pharma INC. | $24.39 | 2024 | Qutenza |
| Abbvie INC. | $24.20 | 2024 | |
| Mindray Ds USA, INC. | $23.71 | 2023 | Te7 Max, Te X |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $23.34 | 2024 | |
| Almatica Pharma LLC | $20.61 | 2023 | Gralise |
| Nevro Corp. | $18.79 | 2024 | Senza |
| Ibsa Pharma INC. | $15.90 | 2023 | Tirosint, Licart |
| Avanos Medical | $14.09 | 2023 | Standard Rf Disposables |
| Spr Therapeutics, INC | $12.74 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.